Loading
JB Chemicals & Pharmaceuticals Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Chetan Kanabar, was filed 17 Jun 2024.
Insider Decl.
728
Thresholds
n/a
Buy Volume
€4,226
1 ops. · all time
Sell Volume
€179M
196 ops. · all time
Who traded when
BuySaleNikhil Ashokkumar Chopra14 sales
Jason Nestor Vincent D'Souza7 sales
Vikas Khare7 sales
Bhushan Sachdev5 sales
Parmeshwar Bang5 sales
Suresh Amin5 sales
+27 other insiders
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,324 of 26,280 companies
60.7
score / 100
Value33
Quality88
FCF yld1.6%
Earn yld1.8%
EV/EBITDA34.0x
ROE19%
Gross mgn68%
Net mgn17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹2,416.10
Analyst consensus
7 analysts1.67/5
₹1,900.00Target ₹2,328.14(-4%)₹2,744.00
Income statement
Revenue₹40.8B
Gross profit₹27.5B68% margin
EBITDA₹11.4B28% margin
Net income₹7.1B17.1% margin
Valuation
PER (trailing)54.2x
PER (forward)32.8x
P/Book9.3x
Beta0.04
Balance sheet & cash
Market cap₹387.9B
Total debt₹35.9M
Free Cash Flow₹6.2B
Debt / Equity0%
Profitability & ownership
ROE18.7%
ROA12.5%
% insiders49.2%
% institutions30.8%
Last declaration on 19 March 2026
Declarations728 total
11,811 shares@ ₹2,110.000.0068% mcap7.2% of flowEquity SharesSEBI:22bd838d2629eee0602afd4f94863b26963e5bce
31,160 shares@ ₹1,992.4023.6% of flowEquity SharesSEBI:ddd9934c01ddd6cdca4c4e5434df8d26d3460ecd
92,490 shares@ ₹1,600.0055.9% of flowEquity SharesSEBI:d4a5a80f18f9c0ab2daa892a6f6c6cd5cbcd0862
92,490 shares@ ₹1,600.000.1% of flowEquity SharesSEBI:c6bf52f2d6168909ec5614b2d78b6da99ae222f7
92,490 shares@ ₹600.0020.5% of flowEquity SharesSEBI:7c5eaa4b427a346b72122d571a0da04decb73a9b
1,916,596 shares@ ₹1,600.0028.1% of flowEquity SharesSEBI:80d23fc0f965de435327ca1cc57ca40380adce3d
9,000 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:a6bf4bf716f9c1a182e8f701a74d14df0d40780f
6,802 shares@ ₹1,600.0020.5% of flowEquity SharesSEBI:2aa2bcab95596bbc35f3d12c362814e4b5226fa6
12,054 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:c125c8eac0d6a2c0eafd0336ce12330d9a2fa35e
18,000 shares@ ₹1,600.0031.2% of flowEquity SharesSEBI:624453ba29396e0d08ea3f48b6f253efcd3bf62d
8,790 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:2e0222e8406fc4709e69d1df930159344f1d27cc
19,782 shares@ ₹1,600.0023.2% of flowEquity SharesSEBI:e31e12e823462e8639c4eb372e99bfb78a301b91
19,288 shares@ ₹1,600.0026.4% of flowEquity SharesSEBI:9ecdf9e746a0ec4326bbc05e8d5ee27533afad7e
14,650 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:86fb0f035b906729059ba0d0e48e4fa886694b69
9,894 shares@ ₹1,600.0025.5% of flowEquity SharesSEBI:6e6b50c7c0559c3d5a6947358e25c5ce7bf2c9ed
92,489 shares@ ₹1,600.0030.2% of flowEquity SharesSEBI:ff50e1181646b40cdc51ff000bbb62f4464f40d6
41,548 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:3e354c9cffaf59113ffb82d80d0d758732fb1e1f
26,300 shares@ ₹1,600.0037.3% of flowEquity SharesSEBI:f360077d3a4ca575099d1b3cd67c8ae3c2d1e398
9,894 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:c7e0032720be8a5abb0d2a1ec1be6d7bed5891cd
217,534 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:2a1a027ef10ce0abd56033882368f5f6404ef5e6
13,909 shares@ ₹1,600.0037.0% of flowEquity SharesSEBI:7a0cc00d00a1ca2f7630a508797a6dce7d79a987
9,894 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:fcc2ca6368a0f17183371eabccce86e282bb0660
168,468 shares@ ₹1,600.0038.0% of flowEquity SharesSEBI:379af58d96ceda2daec2f8227b02ab1a661d2b04
62,321 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:27ed90e1220aee8d0c028d2c3755a8ed4c11747c
51,934 shares@ ₹1,600.0045.7% of flowEquity SharesSEBI:546f7017d6e07a5bae22c58f5b794ff11554480c
25 of 728 declarations
About JB Chemicals & Pharmaceuticals Limited
JB Chemicals & Pharmaceuticals Limited is an Indian healthcare company worth INR 387.9 billion, with 49.2% of its capital held by insiders and 91 filers in the record. It is almost exclusively on the selling side: 196 sales worth EUR 178.6 million (median EUR 30,502) against a single purchase, EUR 4,226, filed by Chetan Kanabar on June 13, 2024, or 1% of open-market trades.
One sale carries almost all of it: EUR 158,538,629 for Tau Investment Holdings Pte. Ltd. on March 27, 2025. Nikhil Ashokkumar Chopra, a director, sold EUR 1,984,871 on August 6, 2025 and EUR 1,714,183 on August 22, 2025. He has 43 filings of which 14 are sales; Nikhil Chopra, with no declared role, 47 of which 11, ahead of Parmeshwar Bang (38) and Pradeep Kumar Singh (32).
Read moreShow less
The record gathers 724 filings, 276 of another kind and 251 grants, with a volume of 5 in 2021, 250 in 2024, 191 in 2025 and 100 in 2026. The median publication delay is 1 day. Over the last twelve months: 110 filings, 6 sales and no purchase.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
